<SEC-DOCUMENT>0001781002-24-000048.txt : 20241003
<SEC-HEADER>0001781002-24-000048.hdr.sgml : 20241003
<ACCEPTANCE-DATETIME>20241003162242
ACCESSION NUMBER:		0001781002-24-000048
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20241003

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MDxHealth SA
		CENTRAL INDEX KEY:			0001872529
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MEDICAL LABORATORIES [8071]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			C9

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-93034
		FILM NUMBER:		241351813

	BUSINESS ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000
		BUSINESS PHONE:		949-271-9221

	MAIL ADDRESS:	
		STREET 1:		CAP BUSINESS CENTER
		STREET 2:		RUE D'ABHOOZ, 31, B-4040
		CITY:			HERSTAL
		STATE:			C9
		ZIP:			00000

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MDx Health SA
		DATE OF NAME CHANGE:	20210713

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Bleichroeder LP
		CENTRAL INDEX KEY:			0001781002
		ORGANIZATION NAME:           	
		IRS NUMBER:				842006600
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		1345 AVENUE OF THE AMERICAS
		STREET 2:		47TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10105
		BUSINESS PHONE:		917-769-2999

	MAIL ADDRESS:	
		STREET 1:		1345 AVENUE OF THE AMERICAS
		STREET 2:		47TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10105
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><!-- EDGARfilingagent.com Schedule 13D/G Online Workstation (https://schedule13d.com) --><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
	<submissionType>SCHEDULE 13G/A</submissionType>
	<previousAccessionNumber>0001781002-21-000045</previousAccessionNumber>
	<filerInfo>
		<filer>
			<filerCredentials>
				<cik>0001781002</cik>
				<ccc>XXXXXXXX</ccc>
			</filerCredentials>
		</filer>
		<liveTestFlag>LIVE</liveTestFlag>



	</filerInfo>
</headerData>
<!-- Start Form -->
  <formData>
<!-- Issuer Cover Page-->
    <coverPageHeader>
		<amendmentNo>4</amendmentNo>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2024</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001872529</issuerCik>
        <issuerName>MDxHealth SA</issuerName>
        <issuerCusip>58286E102</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>CAP Business Center</com:street1>
          <com:street2>Zone Industrielle des Hauts-Sarts</com:street2>
          <com:city>Herstal</com:city>
          <com:stateOrCountry>C9</com:stateOrCountry>
          <com:zipCode>4040</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(b)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
<!-- Reporting Persons Cover Page -->
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Bleichroeder LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>8378333</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>8378333</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>8378333</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>17.7</classPercent>
      <typeOfReportingPerson>IA</typeOfReportingPerson>
      <comments>Relating to item 11 on this page: Based on 47,288,093 shares reported by the Issuer to be outstanding</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Bleichroeder Holdings LLC</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>8378333</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>8378333</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>8378333</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>17.7</classPercent>
      <typeOfReportingPerson>HC</typeOfReportingPerson>
      <comments>Relating to item 11 on this page: Based on 47,288,093 shares reported by the Issuer to be outstanding</comments>
    </coverPageHeaderReportingPersonDetails>
<!-- Items -->
    <items>
      <item1>
        <issuerName>MDxHealth SA</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>CAP Business Center, Zone Industrielle des Hauts-Sarts, Herstal, C9  4040</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>Bleichroeder Holdings LLC
Bleichroeder LP

</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>1345 Avenue of the Americas, 47th Floor
New York, NY 10105</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Delaware, USA</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>N</notApplicableFlag>
      <typeOfPersonFiling>IA</typeOfPersonFiling>
      <typeOfPersonFiling>HC</typeOfPersonFiling>
      </item3>
      <item4>
        <amountBeneficiallyOwned>See cover page</amountBeneficiallyOwned>
        <classPercent>See cover page</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>See cover page</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>See cover page</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>See cover page</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>See cover page</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>N</notApplicableFlag>
        <ownershipMoreThan5PercentOnBehalfOfAnotherPerson>Bleichroeder LP ("Bleichroeder"), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 8,378,333 shares, or 17.72%, of the common stock ("Common Stock") reported by the issuer as outstanding. 21 April Fund Ltd., a Cayman Islands company for which Bleichroeder acts as investment adviser, holds 4,014,216 of these 8,378,333 shares, which equates to 8.49% of Common Stock reported by the issuer as outstanding. Hill Family Alternative Investments, a separately managed account for which Bleichroeder acts as an investment adviser, holds 2,500,000 of these 8,378,333 shares, which equates to 5.29% of Common Stock believed to be outstanding. Clients of Bleichroeder have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities.</ownershipMoreThan5PercentOnBehalfOfAnotherPerson>
      </item6>
      <item7>
        <notApplicableFlag>N</notApplicableFlag>
        <subsidiaryIdentificationAndClassification>See exhibit 99.1</subsidiaryIdentificationAndClassification>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.</certifications>
      </item10>
    </items>
	<!-- Exhibit Information -->
	<exhibitInfo>Exhibit 99.1: Subsidiary Information</exhibitInfo>
	<!-- Signature -->
    <signatureInformation>
      <reportingPersonName>Bleichroeder LP</reportingPersonName>
      <signatureDetails>
        <signature>Michael M. Kellen</signature>
        <title>Chairman And CO-CEO</title>
        <date>10/03/2024</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Bleichroeder Holdings LLC</reportingPersonName>
      <signatureDetails>
        <signature>Michael M. Kellen</signature>
        <title>Chairman And CO-CEO</title>
        <date>10/03/2024</date>
      </signatureDetails>
    </signatureInformation>
	</formData>

</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>SUBSIDIARY INFORMATION (320)
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center">Exhibit 99.1</P>

<P>The identity and the Item 3 classification of the relevant subsidiary is: Bleichroeder LP, which is an Investment Adviser
in accordance with Rule 13d-1(b)(1)(ii)(E).</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
